Skip Navigation

European Heart Journal 2002 23(6):429-431; doi:10.1053/euhj.2001.2960
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schaufelberger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaufelberger, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Pulmonary diffusion capacity as prognostic marker in chronic heart failure

M. Schaufelberger

Department of Medicine, Sahlgrenska University Hospital, Östra, Göteborg University, Sweden

References

  1. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation. 1988;77:552–559[Abstract/Free Full Text]
  2. Mancini DM, La Manca J, Donchez L, Henson D, Levine S. The sensation of dyspnoea during exercise is not determined by the work of breathing in patients with heart failure. J Am Coll Cardiol. 1996;28:391–395[Abstract]
  3. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol. 1993;21:641–648[Abstract]
  4. Davies SW, Bailey J, Keegan J, Balcon R, Rudd RM, Lipkin DP. Reduced pulmonary microvascular permeability in severe chronic left heart failure. Am Heart J. 1992;124:137–142[CrossRef][ISI][Medline]
  5. Puri S, Baker BL, Dutka DP, Oakley CM, Hughes JM, Cleland JG. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance. Circulation. 1995;91:2769–2774[Abstract/Free Full Text]
  6. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol. 1978;32:121–140[CrossRef][ISI][Medline]
  7. Pietra GG, Szidon JP, Leventhal MM, Fishman AP. Hemoglobin as a tracer in hemodynamic pulmonary edema. Science. 1969;166:1643–1646[Abstract/Free Full Text]
  8. Weibel ER. The pathway of oxygen. Cambridge: Harvard University Press; 1984.
  9. West JB, Mathieu-Costello O. Structure, strength, and remodeling of the pulmonary blood-gas barrier. Ann Rev Physiol. 1999;61:543–572[CrossRef][ISI][Medline]
  10. West JB, Tsukimoto K, Mathieu-Costello O, Prediletto R. Stress failure in pulmonary capillaries. J Appl Physiol. 1991;70:1731–1742[Abstract/Free Full Text]
  11. Elliott AR, Fu Z, Tsukimoto K, Prediletto R, Mathieu-Costello O, West JB. Short-term reversibility of ultrastructural changes in pulmonary capillaries caused by stress failure. J Appl Physiol. 1992;73:1150–1158[Abstract/Free Full Text]
  12. Kay JM, Edwards FR. Ultrastructure of the alveolar-capillary wall in mitral stenosis. J Pathol. 1973;111:239–245[CrossRef][ISI][Medline]
  13. Lee YS. Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J. 1979;43:945–954[Medline]
  14. Kay JM, de Sa DJ, Mancer JF. Ultrastructure of lung in pulmonary veno-occlusive disease. Hum Path. 1983;14:451–456[ISI][Medline]
  15. Ryan JW, Ryan US, Schultz DR, Whitaker C, Chung A. Subcellular localization of pulmonary angiotensin converting enzyme (kinase II). Biochem J. 1975;146:497–499[ISI][Medline]
  16. Guazzi M, Marenzi G, Alimento M, Contini M, Agostoni P. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation. 1997;95:1930–1936[Abstract/Free Full Text]
  17. Guazzi M, Agostoni P. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane. Clin Sci. 1999;96:17–22[Medline]
  18. Ewert R, Wensel R, Bettmann M. Ventilatory and diffusion abnormalities in long-term survivors after orthotopic heart transplantation. Chest. 1999;115:1305–1311[Abstract/Free Full Text]
  19. Dimopoulou I, Tsintzas OK, Daganou M, Cokkinos DV, Tzelepis GE. Contribution of lung function to exercise capacity in patients with chronic heart failure. Respiration. 1999;66:144–149[CrossRef][ISI][Medline]
  20. Guazzi M, Pontone G, Brambilla R, Agostoni P, Reina G. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J. 2002;23:467–476[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schaufelberger, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaufelberger, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?